Psychedelics Today, an education company, will soon be launching an in-depth, 12-month training focused on psychedelic therapy and integration.
“In the current marketplace, there’s actually a gap,” the company’s director of operations and strategic growth, David Drapkin, told Fierce Healthcare. Demand for psychedelic therapy is thriving, but the field remains available primarily only to clinicians. As a result, many are giving therapy in an unregulated space.
Click here to read more.